Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

Leukemia. 2007 Dec;21(12):2540-4. doi: 10.1038/sj.leu.2404828. Epub 2007 Jul 5.

Authors

B Oran, S Giralt, D Couriel, C Hosing, E J Shpall, E de Meis, I F Khouri, M Qazilbash, P Anderlini, P Kebriaei, U Popat, A Carrasco-Yalan, R E Champlin, M de Lima

PMID: 17611563
DOI: 10.1038/sj.leu.2404828

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation* / statistics & numerical data
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / surgery
Leukemia, Myeloid, Acute / therapy*
Lymphocyte Transfusion* / statistics & numerical data
Male
Middle Aged
Myeloablative Agonists / administration & dosage
Myelodysplastic Syndromes / drug therapy
Myelodysplastic Syndromes / surgery
Myelodysplastic Syndromes / therapy*
Palliative Care
Recurrence
Remission Induction
Salvage Therapy*
Transplantation Conditioning / methods*
Transplantation, Homologous

Substances

Immunosuppressive Agents
Myeloablative Agonists